OABI (OmniAb) GF Score: 71/100 (As of Jul. 06, 2026) — 223% Above Median


OABI OmniAb Inc OABI
71 GF Score
Price $2.41
GF Value $2.26
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is OmniAb GF Score?

OmniAb OABI -0.41% 71 GF Score is 71 as of Jul. 06, 2026, which is 223% above its 10-year median of 22.00. GuruFocus rates OABI with a GF Score™ of 71/100 and a GF Value™ of $2.26 (Fairly Valued). The stock has 4 warning signs investors should review.

OmniAb has the GF Score of 71, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 2/10
3. Growth Rank : 6/10
4. GF Value Rank : 7/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes OmniAb is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

OmniAb  (NAS:OABI) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

OmniAb GF Score Related Terms

OABI vs VNDA, AVIR, UPB: GF Score Comparison

For the Biotechnology subindustry, OmniAb's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OmniAb GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OmniAb's GF Score distribution charts can be found below:

* The bar in red indicates where OmniAb's GF Score falls into.


OABI
71GF Score
OmniAb Inc OABI
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 71 mean?
OmniAb (OABI) has a GF Score of 71 as of Jul. 06, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on OmniAb and its competitors. This is 223% above median its historical median of 22.00. Over the past decade, OmniAb's GF Score has ranged from 16.00 to 78.00.
Is OmniAb's GF Score too high?
OmniAb's current GF Score of 71 is 223% above median its 10-year median of 22.00. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 78.00. Overall, OmniAb has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does OmniAb's GF Score compare to VNDA and AVIR?
OmniAb's GF Score of 71 can be compared against companies in the Biotechnology industry. Historically, OmniAb's own GF Score has ranged from 16.00 to 78.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on OmniAb and its competitors. OmniAb's current GF Score is 71, which is 223% above median its own 10-year median of 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OmniAb stock overvalued right now?
Based on GuruFocus' analysis, OmniAb (OABI) is currently considered Fairly Valued. The stock's GF Value™ is $2.26, compared to a current price of $2.41 — trading 6.6% above its estimated fair value. The current GF Score is 71, which is 223% above median its 10-year median of 22.00. OmniAb's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For OmniAb (OABI), the current GF Score is 71 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OmniAb (OABI) Overvalued in 2026?

Based on GuruFocus' analysis, OmniAb stock appears to be overvalued. The current stock price of $2.41 is trading 6.6% above its estimated GF Value™ of $2.26. GuruFocus considers OmniAb to be Fairly Valued.

Key valuation signals for OABI:

  • GF Score: 71 (223% above median its 10-year median of 22.00)
  • GF Value™: $2.26 vs. price of $2.41 (6.6% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the OABI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OmniAb Business Description

Address 5980 Horton Street, Suite 600, Emeryville, CA, USA, 94608
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
71GF Score

Get the complete analysis for OABI

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.41
Price
$2.26
GF Value